OUR PRODUCT TECHNOLOGY
Verde® Technologies is committed to developing research-based, scientifically proven solutions to reduce drug abuse and misuse. The Deterra® Drug Deactivation System is powered by proprietary MAT12® Molecular Adsorption Technology, which deactivates prescription drugs using activated carbon. The technology is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inert, unavailable for misuse and safe for the environment.
MAT12 Molecular Adsorption Technology
Proprietary activated carbon binds to pharmaceutical compounds, rendering drugs inert, unavailable for misuse and safe for the environment.
Deterra System Technology
A key component of our patented technology is a proprietary activated carbon. Owing to its affinity for organic compounds, activated carbon is considered to be a universal adsorbent. Pharmaceutical molecules and toxins will bind to activated carbon through intermolecular forces, and pharmaceuticals that are bound to the activated carbon will no longer be mobile nor physiologically active (e.g. deactivated). Activated carbon has been frequently administered to patients for the treatment of acute overdose and poisoning in emergency situations. It has been found to effectively bind to a wide variety of drugs and poisons with a few notable exceptions (e.g. iron, lithium, and potassium).